SS
BCYC

SBI Securities’s Bicycle Therapeutics BCYC Stock Holding History

SBI Securities’s Portfolio BCYC Stock Details BCYC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25 Hold
6
– – ﹤0.01% 3804
2026
Q1 		$28 Hold
6
– – ﹤0.01% 3689
2025
Q4 		$42 Sell
6
-1
-14% -$7 ﹤0.01% 3610
2025
Q3 		$54 Buy
7
+1
+17% +$8 ﹤0.01% 3689
2025
Q2 		$42 Hold
6
– – ﹤0.01% 3756
2025
Q1 		$51 Sell
6
-1
-14% -$12 ﹤0.01% 3639
2024
Q4 		$98 Buy
+7
New +$150 ﹤0.01% 3461

Other funds holding BCYC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
FIS
FCPM III Services Naarden, Netherlands $750M AUM 127.27% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.91B AUM 12.68% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
GP
GSK plc London $602M AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $127B AUM 46.06% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

SBI Securities's BCYC Position: Q2 2026 in Review

SBI Securities held its Bicycle Therapeutics (BCYC) position steady in Q2 2026 at 6 shares worth $25. The position accounts for ﹤0.01% of the portfolio, ranked #3804.

SBI Securities first reported a position in BCYC in Q4 2024 and has held it in 7 quarters since. The position peaked at $98 in Q4 2024. 104 funds tracked by Wall St. Rank hold BCYC as of Q2 2026.

  • SBI Securities held 6 shares of Bicycle Therapeutics worth $25 as of Q2 2026.
  • SBI Securities left its Bicycle Therapeutics share count unchanged in Q2 2026.
  • Bicycle Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3804 holding.
  • SBI Securities first reported a position in Bicycle Therapeutics in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Bicycle Therapeutics position peaked at $98 in Q4 2024.
  • 104 funds tracked by Wall St. Rank held Bicycle Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.